4
Changes in Ownership
Teladoc Health, Inc. Filed Acc 0001477449-24-000146
Chief Technology Officer sold 1,040 shares at $11.16 ($11,603)
- Chief Technology Officer acquired 2,854 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Nanis Nikolaos P. · Chief Technology Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-31 | Exercise or conversion : show line 1 in the form | +370 | 70,991 | D | ||
| 2024-05-31 | Exercise or conversion : show line 2 in the form | +505 | 71,496 | D | ||
| 2024-05-31 | Exercise or conversion : show line 3 in the form | +894 | 72,390 | D | ||
| 2024-05-31 | Exercise or conversion : show line 4 in the form | +1,085 | 73,475 | D | ||
| 2024-06-03 | Sale : show line 5 in the form | −1,040 | $11.16 | $11,603 | 72,435 | D |
| Open-market sales · 1,040 sh · avg $11.16 · $11,603 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-31 | Exercise or conversion : show line 6 in the form Performance Stock Units | −370 | 2,588 | D |
| 2024-05-31 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −505 | 1,518 | D |
| 2024-05-31 | Exercise or conversion : show line 8 in the form Restricted Stock Units | −894 | 3,578 | D |
| 2024-05-31 | Exercise or conversion : show line 9 in the form Restricted Stock Units | −1,085 | 7,596 | D |
Loading xslF345X05/wk-form4_1717531514.xml…